Fufang shenhua tablet, astragali radix and its active component astragaloside IV: Research progress on anti-inflammatory and immunomodulatory mechanisms in the kidney

Fufang shenhua tablet, astragali radix and its active component astragaloside IV: Research progress on anti-inflammatory and immunomodulatory mechanisms in the kidney

Background: Given the limited treatment options available for kidney disease, a significant number of patients turn to alternative therapies, including traditional Chinese medicine. Among these therapies, the Fufang Shenhua tablet (SHT) has garnered attention for its effectiveness in addressing the...

Full description

Bibliographic Details
Main Authors:	Run Li, Chunru Shi, Cuiting Wei, Chao Wang, Hongjian Du, Quan Hong, Xiangmei Chen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-04-01
Series:	Frontiers in Pharmacology
Subjects:	Fufang Shenhua Tablet Astragali Radix Astragaloside IV (AS-IV) anti-inflammatory immunity kidney disease
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2023.1131635/full

Similar Items

Effects of Physical Properties and Processing Methods on Astragaloside IV and Flavonoids Content in <i>Astragali radix</i>
by: Mei-Yin Chien, et al.
Published: (2022-01-01)

Untapping the Potential of Astragaloside IV in the Battle Against Respiratory Diseases
by: Tan J, et al.
Published: (2023-07-01)

Astragaloside IV Suppresses Hepatic Proliferation in Regenerating Rat Liver after 70% Partial Hepatectomy via Down-Regulation of Cell Cycle Pathway and DNA Replication
by: Gyeong-Seok Lee, et al.
Published: (2021-05-01)

Astragaloside IV, as a potential anticancer agent
by: Dongqin Xia, et al.
Published: (2023-02-01)

Neuroprotective effect of Astragali Radix on cerebral infarction based on proteomics
by: Ying Li, et al.
Published: (2023-06-01)

Effect of Astragali radix extract on pharmacokinetic behavior of dapagliflozin in healthy and type 2 diabetic rats
by: Wandi Du, et al.
Published: (2023-10-01)

Comparison of the Immune Enhancing Activity and Chemical Constituents Between Imitation Wild and Cultivated Astragali Radix
by: Shuo Zhao, et al.
Published: (2025-02-01)

Cysteine-rich peptide fingerprinting as a general method for herbal analysis to differentiate Radix Astragali and Radix Hedysarum
by: Huang, Jiayi, et al.
Published: (2020)

Residue of Chlormequat and Regulatory Effects on the Specialized Metabolites of Astragali Radix
by: Honghan Qin, et al.
Published: (2023-09-01)

Integrated analysis of metabolome, lipidome, and gut microbiome reveals the immunomodulation of Astragali radix in healthy human subjects
by: Wan-Yu Gui, et al.
Published: (2024-12-01)

Effects of Astragali Radix on T lymphocyte subsets expression in peripheral blood of Hashimoto′s thyroiditis patients with normal thyroid function
by: LI Ziyun, et al.
Published: (2024-01-01)

Comparative analysis of chemical profiles of Radix Astragali between ultrafine granular powder and sliced traditional material
by: Liang Cao, et al.
Published: (2022-01-01)

Germplasm Resources and Genetic Breeding of Huang-Qi (Astragali Radix): A Systematic Review
by: Pengbin Dong, et al.
Published: (2024-08-01)

Deciphering the pharmacological mechanism of Radix astragali for allergic rhinitis through network pharmacology and experimental validation
by: Yiwei Hua, et al.
Published: (2024-12-01)

Genetic diversity of the Chinese medicinal plant Astragali Radix based on transcriptome-derived SSR markers
by: Ming Jiang, et al.
Published: (2023-03-01)

Pharmacological Effects of Astragaloside IV: A Review
by: Yutong Liang, et al.
Published: (2023-08-01)

16S rRNA and Metagenomics Combined with UPLC-Q/TOF-MS Metabolomics Analysis Reveals the Potential Mechanism of Radix Astragali Against Hyperuricemia in Mice
by: Deng S, et al.
Published: (2023-05-01)

RETRACTED: Astragali Radix Isoflavones Synergistically Alleviate Cerebral Ischemia and Reperfusion Injury Via Activating Estrogen Receptor-PI3K-Akt Signaling Pathway
by: Yong Gu, et al.
Published: (2021-02-01)

Astragaloside IV alleviates inflammation and improves myocardial metabolism in heart failure mice with preserved ejection fraction
by: Xiao Wang, et al.
Published: (2024-11-01)

Astragaloside IV-PESV inhibits prostate cancer tumor growth by restoring gut microbiota and microbial metabolic homeostasis via the AGE-RAGE pathway
by: Xujun You, et al.
Published: (2024-04-01)

The Antioxidant Action of <i>Astragali radix</i>: Its Active Components and Molecular Basis
by: Juan Yao, et al.
Published: (2024-04-01)

In vitro colonic fermentation of fermented Radix Astragali by Poria cocos and anti-hyperuricemia mechanism based on network pharmacology and experiment verification
by: Caiyun Chen, et al.
Published: (2024-12-01)

In vivo components analysis of Shenhua tablets active in IgA nephropathy
by: Huiqiang Liu, et al.
Published: (2024-09-01)

Post-harvest processing methods have critical roles on the contents of active metabolites and pharmacological effects of Astragali Radix
by: Xiaoyan Zhang, et al.
Published: (2024-12-01)

Study on the biotransformation and activities of three isoflavone glycosides from Radix Astragali by human feces in vitro
by: Xin Liu, et al.
Published: (2023-08-01)

An evaluation of Astragali Radix with different growth patterns and years, based on a new multidimensional comparison method
by: Yapeng Wang, et al.
Published: (2024-02-01)

Extraction Optimization of Astragaloside IV by Response Surface Methodology and Evaluation of Its Stability during Sterilization and Storage
by: Lin Xu, et al.
Published: (2021-04-01)

Astragaloside IV attenuates glucocorticoid-induced osteoclastogenesis and bone loss via the MAPK/NF-κB pathway
by: Chun Guo, et al.
Published: (2025-02-01)

Isolating, Identifying, and Analyzing the Biological Characteristics of Pathogens Causing Postharvest Disease in Fresh <i>Radix Astragali</i>
by: Yuan Zhang, et al.
Published: (2023-09-01)

Exploring the In Vivo Existence Forms (23 Original Constituents and 147 Metabolites) of Astragali Radix Total Flavonoids and Their Distributions in Rats Using HPLC-DAD-ESI-IT-TOF-MS<sup>n</sup>
by: Li-Jia Liu, et al.
Published: (2020-11-01)

Astragaloside IV- loaded heart-mitochondria dual-targeted nanomicelles improved heart injury after acute myocardial infarction
by: Yang Ke, et al.
Published: (2022-09-01)

Astragaloside IV inhibits colorectal cancer metastasis by reducing extracellular vesicles release and suppressing M2-type TAMs activation
by: Jing Zhou, et al.
Published: (2024-05-01)

Astragaloside IV attenuates neuroinflammation and ameliorates cognitive impairment in Alzheimer’s disease via inhibiting NF-κB signaling pathway
by: Li He, et al.
Published: (2023-02-01)

The Molecular Basis of the Anti-Inflammatory Property of Astragaloside IV for the Treatment of Diabetes and Its Complications
by: Li L, et al.
Published: (2023-03-01)

Advances in Chemical Composition, Extraction Techniques, Analytical Methods, and Biological Activity of <i>Astragali Radix</i>
by: Xiangna Chang, et al.
Published: (2022-02-01)

Review on the protective mechanism of astragaloside IV against cardiovascular diseases
by: Chunkun Yang, et al.
Published: (2023-05-01)

Anti-Mutagenic and Immunomodulatory Effects of Astragali Radix Extract on a Cyclophosphamide-Induced Immunosuppressed Mouse Model
by: Hye-Rim Park, et al.
Published: (2023-02-01)

Effect of Astragaloside IV on improving cardiac function in rats with heart failure: a preclinical systematic review and meta-analysis
by: Zhiyuan Zhang, et al.
Published: (2023-10-01)

Astragaloside IV attenuates sunitinib-associated cardiotoxicity by inhibiting COUP-TFII
by: Wanting Qin, et al.
Published: (2024-02-01)

Single-cell RNA sequencing reveals cellular dynamics and therapeutic effects of astragaloside IV in slow transit constipation
by: Huaxian Chen, et al.
Published: (2024-01-01)